Try our Advanced Search for more refined results
Intellectual Property
Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
Sign up for a 7-day FREE trial today!
Latest News in Intellectual Property
-
February 26, 2026
X Corp. Beats OnlyFans Creator's Revenge Porn Suit
A Texas federal judge has tossed an OnlyFans creator's proposed class action that sought to hold X Corp. liable under a revenge porn statute after someone shared his photos on the social media platform, saying the creator's images had not been "produced" by fraud or misrepresentation as required for damages.
-
February 26, 2026
Patent Examiner Settles Ethics Probe For $500K
A veteran patent examiner has agreed to pay half a million dollars to settle claims that she prosecuted patents for companies in which she had a financial interest, according to the U.S. Department of Justice.
-
February 26, 2026
Tech. Co. Says DHS Infringed Its Surveillance Tech Patents
A Florida-based tech company has accused the Department of Homeland Security of infringing five of its patents on surveillance analytics, saying the agency failed to get licenses to use the technology for immigration enforcement and surveillance programs inside the U.S.
-
February 26, 2026
Antitrust Claims Over Oil Tubing Patents Saved By Fed. Circ.
The Federal Circuit on Thursday undid a Texas federal judge's conclusion that a company intended to defraud the U.S. Patent and Trademark Office when it got a patent on coiled tubing, but also revived claims accusing it of using fraudulently obtained patents to get a monopoly.
-
February 26, 2026
Justices Told 'Skinny Label' Case Puts Generic Drugs At Risk
The U.S. government, one named sponsor of the Hatch-Waxman Act, a generic-drug industry group and more have warned the U.S. Supreme Court that a decision that allowed a patent case involving a so-called skinny label to proceed threatens the availability of low-cost generic drugs.
Areas of Coverage
- LITIGATION
- Infringement suits over patents, copyrights, and trademarks
- Patent Trial and Appeal Board disputes
- Abbreviated New Drug Application (ANDA) litigation
- Section 301 cases
- Trade secrets disputes
- Licensing and royalty fights
- Right-of-publicity suits
- Antitrust disputes involving IP issues
- AGENCIES
- U.S. Patent and Trademark Office
- U.S. Copyright Office
- U.S. International Trade Commission
- World Intellectual Property Organization
- POLICY & REGULATION
- Patent reform legislation and related bills in Congress
- Efforts to streamline international intellectual property law
- ENFORCEMENT
- Piracy and counterfeiting actions
- International trade disputes involving IP issues
- PROFILES
- Personnel moves
- Profiles of IP practices
Readership
- Intellectual property lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the life sciences, technology, and other IP-focused industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals